NAD+

NAD+ (also known as Nicotinamide Adenine Dinucleotide, NAD Plus, Beta-Nicotinamide Adenine Dinucleotide) is a prominently researched experimental compound classified strictly within the Longevity framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it nAD+ is a critical coenzyme in every cell, essential for mitochondrial energy production (oxidative phosphorylation), DNA repair via PARP and sirtuin activation, and circadian rhythm regulation. Levels decline ~50% between ages 40-60, contributing to metabolic dysfunction and aging. with a documented biological half-life of roughly 4 hours, In preclinical investigative trials and independent academic studies, researchers utilizing NAD+ have documented significant, quantifiable biological outcomes, primarily focusing on cellular energy, dna repair, longevity. Typical research protocols investigate administering 50000 to 200000mcg via subq pathways daily. However, it is critically important to understand that while NAD+ demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.